Found 13 clinical trials
Study of Hemostasis During the Atrial Fibrillation Ablation Procedure (EHPAFAVE)
Due to the high thrombotic risk during the atrial fibrillation procedure, new guidelines have been proposed to maintain direct oral anticoagulant therapy during the perioperative period. This resulted in a significant change in the activated clotting time (ACT) at the beginning of the procedure, making it difficult to assess the …
- 0 views
- 22 Nov, 2021
- 1 location
- Online study
Sulodexide VESSEL for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
The study aims at optimizing extended management of elderly patients (> 75 years) with at least one of the known bleeding risk factor, who suffered from first episode of venous thromboembolism of the lower extremity (proximal deep vein thrombosis with or without pulmonary embolism) (VTE). Patients were randomized to receive …
- 0 views
- 16 Feb, 2024
- 1 location
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Whether isolated SSPE represents "true" PE, a clinically more benign form of PE, a physiologic lung clearing process, or a false positive result (artifact) is currently unclear and hence, whether patients with isolated SSPE benefit from anticoagulant treatment is uncertain. Despite growing evidence from observational studies that withholding anticoagulation may …
- 0 views
- 16 Feb, 2024
- 31 locations
Restart Anticoagulation in Patients With Spontaneous Intracerebral Hemorrhage and Mechanical Heart Valves
Medical documents and patient data were reviewed, including patient age, gender, type of mechanical heart valve, replacement time, replacement site, underlying disease, anticoagulant drugs at admission, type of cerebral hemorrhage, treatment mode, time without anticoagulant, length of stay, mortality, etc
- 0 views
- 05 Aug, 2020
Thrombo-Elastography Guided Management of ECMO
Anticoagulation and coagulation management during ECMO is a challenge. Bleeding and clotting are major sources of morbidity and mortality. The currently used strategies are of poor evidence. This observational study wants to evaluate the use of automated thromboelastography (TEG 6s) to guide the management of coagulation and anticoagulation in patients …
- 0 views
- 16 Feb, 2024
- 1 location
Anticoagulation in Emergency General Surgery
While DOACs are increasing in use in the EGS patient population, the risk of bleeding and the reversal of these agents to reduce hemorrhage is still evolving. Given the paucity of data regarding the impact of DOACs in this patient population, it becomes empiric to identify bleeding patterns and outcomes …
- 0 views
- 16 Feb, 2024
- 1 location
Ionized Magnesium for Monitoring of Citrate-anticoagulated CVVHD
It has been reported in several studies that ionized hypomagnesemia is associated with higher morbidity and mortality rates. During continuous renal replacement therapy with regional citrate anticoagulation (CRRT-RCA), the loss of magnesium has been reported to not be covered by magnesium concentration in ordinary dialysis fluid. This may lead to …
- 0 views
- 16 Feb, 2024
- 1 location
Biomarkers of CASH
The project aims to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with cavernous angiomas, a critical clinical challenge in a disease affecting more than a million Americans. We further examine whether blood biomarkers can replace or enhance the accuracy of advanced imaging in association …
- 0 views
- 05 Jan, 2021
Aspirin Thromboprophylaxis After First-line Total Hip and Knee Replacement (TBP-ASPIR)
Annually, more than 100,000 total hip prostheses (THA) and more than 100,000 total knee prostheses (TKA) are implanted for osteoarthritis in France, and these figures are set to increase significantly in the future as in all industrialized countries. . Venous thrombosis is a potentially serious complication after PTH and PTG, …
- 0 views
- 02 Sep, 2022
- 5 locations
Descriptive Study of Acute Spontaneous Spinal Cord Infarction
Given the severe prognosis, conventional treatment of strokes (thrombolysis, anticoagulant and antiplatelet), could be considered on an individual scale, in a specific protocol. A better knowledge of radio-clinical and security factors are necessary to support this approach.
- 0 views
- 16 Feb, 2024
- 1 location
- 1
- 2